Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer

06.03.25 13:30 Uhr

Werte in diesem Artikel
Aktien

96,00 EUR -1,40 EUR -1,44%

WARSAW, Ind., March 6, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kristen Cardillo as Senior Vice President, Chief Communications Officer. Reporting to President and CEO Ivan Tornos, Ms. Cardillo will join the Company on March 10, 2025, to lead Zimmer Biomet's global communications strategy, enhancing engagement with key stakeholders and amplifying the Company's position as a leader in MedTech.

Kristen Cardillo

"Kristen's expertise in shaping compelling corporate narratives and leading high-impact communications strategies will be invaluable as we continue driving Zimmer Biomet's bold vision forward," said Ivan Tornos, President and CEO, Zimmer Biomet. "Her leadership will help amplify our innovation story, strengthen engagement with key internal and external stakeholders, and further elevate our brand in the MedTech industry. I'm excited to welcome Kristen to the team and look forward to the contributions she will make."

Ms. Cardillo joins Zimmer Biomet from life science tools company 10x Genomics, where she was Vice President of Corporate Communications. Previously she served as Vice President of Global Communications and Public Relations for Becton, Dickinson and Company (BD). In this role, Ms. Cardillo played an integral part in advancing BD's strategy, brand and culture through internal communications, public and media relations, social media and financial communications. Prior to BD, she held positions of increasing responsibility in internal and external communications with CareFusion and Cardinal Health.

Ms. Cardillo holds a Bachelor of Science degree in Telecommunications from Ohio University.

About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.

Media
Heather Zoumas-Lubeski
445-248-0577
heather.zoumaslubeski@zimmerbiomet.com

Investors
David DeMartino
646-531-6115
david.demartino@zimmerbiomet.com

Zach Weiner
908-591-6955
zach.weiner@zimmerbiomet.com

(PRNewsfoto/Zimmer Biomet Holdings, Inc.)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-names-kristen-cardillo-as-senior-vice-president-chief-communications-officer-302393822.html

SOURCE Zimmer Biomet Holdings, Inc.

Ausgewählte Hebelprodukte auf Zimmer Biomet

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Zimmer Biomet

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Zimmer Biomet

Wer­bung

Analysen zu Zimmer Biomet

DatumRatingAnalyst
30.07.2019Zimmer Biomet Equal WeightBarclays Capital
24.04.2019Zimmer Biomet Strong BuyNeedham & Company, LLC
03.01.2019Zimmer Biomet HoldDeutsche Bank AG
16.10.2018Zimmer Biomet UnderweightBarclays Capital
16.08.2018Zimmer Biomet NeutralBTIG Research
DatumRatingAnalyst
24.04.2019Zimmer Biomet Strong BuyNeedham & Company, LLC
13.08.2018Zimmer Biomet BuyNeedham & Company, LLC
30.07.2018Zimmer Biomet Strong BuyNeedham & Company, LLC
27.04.2018Zimmer Biomet Strong BuyNeedham & Company, LLC
31.01.2018Zimmer Biomet BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
30.07.2019Zimmer Biomet Equal WeightBarclays Capital
03.01.2019Zimmer Biomet HoldDeutsche Bank AG
16.08.2018Zimmer Biomet NeutralBTIG Research
30.06.2017Zimmer Biomet NeutralCantor Fitzgerald
04.03.2016Zimmer HoldArgus Research Company
DatumRatingAnalyst
16.10.2018Zimmer Biomet UnderweightBarclays Capital
05.10.2011Zimmer sellCitigroup Corp.
24.07.2008Zimmer Holdings underperformCredit Suisse Group
08.11.2007Zimmer Holdings underperformCredit Suisse Group
28.09.2005Update Zimmer Holdings Inc.: Market UnderperformJMP Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Zimmer Biomet nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"